Status:

UNKNOWN

Coronary Calcification Study - Intravascular Lithotripsy for Calcified Lesions

Lead Sponsor:

University Hospital Ostrava

Conditions:

Coronary Artery Calcification

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The aim of this prospective randomised study is to compare the safety and efficacy of novel intravascular lithotripsy (IVL) to the standard therapy of calcified coronary lesions.

Detailed Description

The study will include a total of 40 patients with calcified coronary lesions who will be randomised 1:1 to the treatment with IVL (Shockwave; Shockwave Medical, Inc, Santa Clara, USA) or the standard...

Eligibility Criteria

Inclusion

  • Age ≥18 years
  • Informed, written consent by the patient
  • Ability to comply fully with the study protocol
  • Negative pregnancy test (and effective contraception) in women with childbearing potential
  • Angiographic inclusion criteria:
  • Native coronary artery lesion with diameter stenosis ≥50% suitable for PCI
  • Heavy calcification, defined as calcification within the lesion on both sides of the vessel assessed during angiography
  • Reference vessel diameter (RVD) ≥2.5 mm with lesion length \<32 mm
  • TIMI flow 3 of the target vessel at baseline
  • No visible thrombus at target lesion site

Exclusion

  • Cardiogenic shock or haemodynamic instability requiring mechanical circulatory support
  • Active malignancy or other comorbidities with a life expectancy of 12 months
  • Limited the possibility of control coronaro angiography (e.g., advanced renal failure)
  • Known allergy to contrast agents (that cannot be adequately premedicated) or required concomitant dual antiplatelet therapy
  • Current problems with substance abuse (e.g., alcohol or drugs)
  • Subject is participating in another investigational drug or device clinical study

Key Trial Info

Start Date :

June 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04428177

Start Date

June 1 2020

End Date

December 31 2023

Last Update

September 11 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Cardiovascular Diseases, University Hospital

Ostrava, Česká Republika, Czechia, 70852